The Prescription Drug Affordability Board (PDAB) posted its draft agenda and meeting materials for the November 19 meeting. Check the PDAB website for updates to the agenda and the meeting materials. Register in advance.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Prescription Drug Affordability Board (PDAB) posted its draft agenda for the November 19 meeting. Check the PDAB website for updates to the agenda and the meeting materials. Register in advance.
Also in Oregon, the Oregon Health Authority issued a notice of proposed rulemaking amending prior authorization criteria and preferred drug list to implement recommendations from the Drug Utilization Review / Pharmacy & Therapeutics action. A hearing is scheduled to be held on November 17 from 11:00 am – 11:45 am. See notice for details.
Finally in Oregon, the Office of Governor Tina Kotek and Oregon Health Authority's (OHA) Public Health Division are seeking applicants for one position (member at large) on the state Public Health Advisory Board (PHAB). Please refer to the announcement for more information.
OHA invites applicants from a wide range of backgrounds including pharmacists with experience in prevention, patient care or a public health issue. This term for this position is scheduled to begin January 1, 2026.
Learn about the application process here.
To apply, complete the electronic application process by November 30.
These recruitments will remain open until filled.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Board of Pharmacy posted the agenda for its November 5 Strategic Planning Meeting agenda. The Board will meet virtually, and the meeting begins at 9:00 am.
Also in Oregon, the Board of Pharmacy Board of Pharmacy is proposing to adopt the following rules:
The filing notices and proposed rule text are available on the Board’s website.
The November 25 Rulemaking Hearing will be held virtually via Teams and begins at 9:30 am.
If you wish to provide virtual oral testimony during the hearing, please complete and submit the Rulemaking Hearing Testimony Sign Up Form on the Board’s website. You may also sign up by submitting your first and last name, email address and which rule(s) you would like to comment on to pharmacy.rulemaking@bop.oregon.gov no later than 9:00 on November 25. You will receive a confirmation email and a calendar invitation to join the virtual hearing.
Written comments must be received by 4:30 pm on November 25. Submit written comments to pharmacy.rulemaking@bop.oregon.gov.
If you would like to listen to the rulemaking hearing, join the virtual Teams meeting or call:
(503) 446-4951 Phone Conference ID: 739 529 152#
Please email all rulemaking inquiries to pharmacy.rulemaking@bop.oregon.gov.
Finally in Oregon, the Board of Pharmacy permanently adopted the following rules at the October 2025 board meeting: Div 110 – Licensee & Registrant Fee Increase.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Division of Financial Regulation (DFR) recently hired Sarah Young as the executive director of the Prescription Drug Affordability Board and the Drug Price Transparency Program.
Also in Oregon, the Prescription Drug Affordability Board published its October 2025 quarterly newsletter.
Also in Oregon, the Prescription Drug Affordability Board (PDAB) posted its draft agenda and meeting materials for the October 15 meeting. Check the PDAB website for updates to the agenda and the meeting materials. Register in advance.
Finally in Oregon, the Board of Pharmacy posted The Public Health & Pharmacy Formulary Advisory Committee (PHPFAC) October 22 meeting agenda. Please note that the Committee will meet in Executive Session after approving the agenda and anticipates resuming Open Session between 9:45 am-10:00 am. Please see the agenda for additional information including the link to join the virtual Teams meeting. For more information, contact pharmacy.formulary@bop.oregon.gov.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Prescription Drug Affordability Board (PDAB) posted its draft agenda for the October 15 meeting. Check the PDAB website for updates to the agenda and the meeting materials. Register in advance.
Also in Oregon, the Oregon Health Authority Health Systems Division: Medical Assistance Programs issued a Notice of Proposed Rulemaking to amend rules to provide updates to Health Related Social Needs (HRSN) services covered in the Oregon Health Plan. Please note opportunities for food retailers related to Fruit and Vegetable Benefit Card, Fruit and Vegetable Box and Pantry Stocking Benefit. A hearing will be held on October 15 from 1:00 pm-1:45 pm. The last day and time to offer comments to the agency is October 21 at 5:00 pm.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The West Coast Health Alliance, comprised of California, Hawaii, Oregon and Washington, jointly announced Consensus 2025-26 Respiratory Virus Immunization Recommendations for COVID-19, influenza and respiratory syncytial virus (RSV) vaccines. The recommendations state that immunization is safe and effective, and it offers the best protection available against respiratory viruses. The recommendations also endorse broad access to the COVID-19 vaccine for anyone who chooses protection.
Also in Oregon, at the Board of Pharmacy Special Meeting on September 17, the board adopted the following Temporary Rules and Vaccination Protocols:
September 17 Temporary Rule Noticed
Email all rulemaking related inquiries to pharmacy.rulemaking@bop.oregon.gov.
Also in Oregon, the Division of Financial Regulation issued Bulletin No. DFR 2025-6 regarding coverage of the COVID-19 vaccination. This bulletin clarifies the division's expectations around the coverage of COVID-19 vaccination by health benefit plans in the state in accordance with Bulletin No. DFR 2021-1. For more information, please visit the FAQs about COVID-19 vaccine insurance coverage requirements related to the West Coast Health Alliance.
Finally in Oregon, the Board of Pharmacy posted its agenda and meeting materials for the October 8-10 meeting. Please note on October 8 the board will meet in Executive Session for most of the day and anticipates resuming Open Session around 4:30 pm and on October 9 the board anticipates meeting in Executive Session after roll call and resuming Open Session at 1:00 pm. The board anticipates meeting in Open Session on October 10 and will break for lunch between 12:00 noon-1:00 pm. Please be advised that additional meeting materials may be added to the agenda prior to the board meeting. Visit the board website for current meeting materials.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
On August 13, the Board of Pharmacy adopted Temporary Rule OAR 855-115-0345 updating the Standard Vaccination Protocols to include the CDC's Advisory Committee on Immunization Practices (ACIP) recommendations for the 2025-2026 influenza season.
The ACIP guidance, adopted on July 22, reaffirmed recommendations for the routine annual influenza vaccination of all persons aged ≥6 months who do not have contraindications for the 2025-2026 season.
ACIP recommends only single-dose formulations of annual influenza vaccines that are free of thimerosal as a preservative for three populations:
Please remember licensees are required to follow the age restrictions set forth by state law in ORS 689.645.
Also in Oregon, the Board of Pharmacy permanently adopted the following rules at the August 2025 board meeting:
Review the Secretary of State filing notices on the rulemaking page.
Review the Standard Vaccination Protocols located on the Public Health & Pharmacy Formulary Advisory Committee / Protocols page.
Email all rulemaking related inquiries to pharmacy.rulemaking@bop.oregon.gov.
Also in Oregon, the Oregon Health Authority issued a Notice of Proposed Rulemaking amending pharmacy dispensing, prescription requirements and regulatory cleanup of program rules as follows. A hearing will be held on September 18 from 1:30 pm – 2:15 pm and comments are due to the agency by 5:00 pm on September 21; see notice for details.
Finally in Oregon, the Prescription Drug Affordability Board posted its draft agenda and meeting materials for the August 20 meeting. Register in advance.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Division of Financial Regulation recently announced the following permanent rulemaking that took effect on August 1:
ID 6-2025: Updates to Pharmacy Benefit Manager Rules and DPT Insurer Reporting Rule
Rules: 836-053-1630, 836-200-0401, 836-200-0406, 836-200-0411, 836-200-0416, 836-200-0418, 836-200-0421, 836-200-0436, 836-200-0440
This rulemaking replaces references to registration throughout the current rules, encoded at OAR 836- 200-0401 et seq with references to licensure. It also adds new data elements to the reporting rule and new market conduct requirements. It also adds language clarifying the bar on retaliation against pharmacies, noting that a pharmacy claims audit may be considered retaliation under certain circumstances. Finally, the rulemaking includes substantial revisions to the language related to pharmacy reimbursement in order to clarify expectations for PBMs when a pharmacy is reimbursed below acquisition cost under a maximum allowable cost schedule.
Also in Oregon, the Prescription Drug Affordability Board posted its draft agenda for the August 20 meeting. Register in advance.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The August 6-8 Board of Pharmacy meeting agenda and meeting materials are available. Please note on August 6, the board will meet in Executive Session for most of the day and anticipates resuming Open Session around 4:30 pm. Also note on August 7, the board anticipates meeting in Executive Session after roll call and resuming Open Session at 1:00 pm.
Finally, the board anticipates meeting in Open Session on August 8 and will break for lunch between 12 noon to 1:00 pm. Please see the meeting agenda for additional information. Additional meeting materials may be added to the agenda prior to the board meeting. Visit the board website for current meeting materials.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
